Risk Reduction clinical trials at UCSD
1 research study open to eligible people
open to eligible people ages 18-65
Persons with schizophrenia and other serious mental illnesses have a high risk for type 2 diabetes and an increased risk of premature mortality compared to the general population. The goals of the proposed study are to implement a multimodal lifestyle intervention to reduce that risk in these individuals living in residential care facilities, a common housing modality for people with serious mental illnesses. If successful, this intervention will lead to reduction in excess medical comorbidity and mortality in persons with serious mental illnesses.
La Jolla, California
Our lead scientists for Risk Reduction research studies include Dilip V Jeste, MD.